---
schema_version: "secwatch.filing_event.v1"
accession: "0001651944-23-000060"
form_type: "8-K"
ticker: null
cik: "0001651944"
company_name: "DermTech, Inc."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:24:11.064722+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DermTech shareholders approve doubling authorized shares and expanding equity incentive plan

## Summary
- Authorized common stock increased from 50M to 100M shares; approved by 20.6M votes for, 2.3M against.
- 2020 equity plan evergreen raised from 3.5% to 5% of outstanding shares annually, extended through FY2030.
- Nathalie Gerschtein Keraudy elected as Class III director until 2026; board size reduced to seven.
- Proposal to add officer exculpation under Delaware law failed; KPMG LLP ratified as auditor.
- Plan amendment allows up to 75M shares for ISOs; aggregate grant cap for non-employee directors set at $600K.

## SEC filing metadata
- accession: 0001651944-23-000060
- form_type: 8-K
- cik: 0001651944
- company_name: DermTech, Inc.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/0001651944-23-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/dmtk-20230531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651944-23-000060
- JSON: https://secwatch.observer/filing/0001651944-23-000060.json
- Plain text: https://secwatch.observer/filing/0001651944-23-000060.txt

## Key facts
- Governance Changes
  DermTech, Inc.: The company filed an amendment to its certificate of incorporation to increase authorized shares of common stock from 50,000,000 to 100,000,000 (effective 2023-06-02).
  - Change: charter amendment
  - Effective: 2023-06-02
  source text: On June 2, 2023, the Company filed an amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase the authorized number of shares of common stock of the Company from 50,000,000 to 100,000,000 shares (the “Amended Certificate”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/0001651944-23-000060-index.htm
- Shareholder Votes
  DermTech, Inc. shareholders approved Amendment to the DermTech, Inc. 2020 Equity Incentive Plan to Modify the Plan’s Evergreen Provision at the 2023-05-31 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: The Plan Amendment was approved by the Company’s stockholders at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/0001651944-23-000060-index.htm
- Shareholder Votes
  DermTech, Inc. shareholders voted on Election of Directors at the 2023-05-31 meeting.
  - Proposal: director election
  - Meeting: 2023-05-31
  source text: The Plan Amendment was approved by the Company’s stockholders at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 31, 2023, the results of which are reported below in Item 5.07
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/0001651944-23-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.